MedTrace Logo

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

NCT00405496 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2006-11-30

No results posted yet for this study

Summary

The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.

Conditions

  • Anterior Uveitis

Interventions

DRUG

Difluprednate Ophthalmic Emulsion

Sponsors & Collaborators

  • Sirion Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Kanjiro Masudo · Director, Kanto Rosai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Completion
2001-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00405496 on ClinicalTrials.gov